代谢综合征对冠心病冠状动脉支架术后患者临床事件的影响

目的探讨代谢综合征(MS)对冠状动脉(冠脉)支架术后临床事件发生率的影响。方法自2000年至2006年115例冠脉支架术后的患者,50例置入金属裸支架(BMS),65例置入药物涂层支架(SES)。分组:(1)无MS组;(2)MS组。比较主要心脏不良事件(MACE)发生率。结果两组基础临床资料差异无统计学意义,置入BMS组,MS与对照组MACE发生率分别为20.8%、20.0%,P>0.05;置入SES组,MS与无MS组MACE发生率分别为6.4%、4.7%,差异无统计学意义(P>0.05)。结论MS是冠心病的独立危险因素,且合并MS的冠心病冠脉血管病变较严重,但是MS对于冠脉支架术后MACE发生率无明显影响。

Impact of metabolic syndrome on recent clinical events after coronary stenting

Objective To evaluate the impact of metabolic syndrome on recent clinical events after coronary stenting.Methods A total of 115 patients after coronary stenting from 2000 to 2006 were divided into metabolic syndrome group(MS group) and control group,including 50 with bare metal stenting(BMS) and 65 with sirolimus eluting stenting(SES).Major adverse cardiac event(MACE) rates of the two groups were compared.Results There were no differences in baseline clinical data between two groups.In BMS group,there was no difference in MACE rate between MS group and control group(20.8% vs.20%,P>0.05).In SES group,there was also no difference in MACE rate between MS group and control group(6.4% vs.4.7%,P>0.05).Conclusion Metabolic syndrome(MS) is an independent risk factor for coronary heart disease.But it has no effect on the incidence of MACE after coronary stenting.